A 10-Year Experience of Leiomyosarcoma of the Inferior Vena Cava.

Jun Pan,Chen-yang Qiu,Yang-yan He,Xing Xue,Dong-lin Li,Lu Tian,Fei Cheng,Zi-heng Wu,Hong-kun Zhang
DOI: https://doi.org/10.1177/02683555221101706
2022-01-01
Phlebology The Journal of Venous Disease
Abstract:Objectives Leiomyosarcoma of the inferior vena cava (IVC) is rare. The study reviewed patients with IVC leiomyosarcoma in our hospital in the past ten years. Methods Twenty patients diagnosed with IVC leiomyosarcoma between October 2010 and October 2020 were enrolled. Their clinical manifestations, treatments, and follow-up results were analyzed. Results The sarcoma was located in the lower IVC segment in six patients, with 13 in the middle and one in the upper IVC segment. Eighteen patients underwent R0 resection. After resection, 16 patients (80%) had primary repair of the IVC, while four patients underwent ligation. During a mean follow-up of 37.7 months, seven patients died due to tumor metastasis, four patients were alive with the tumor recurrence and other nine patients were alive without recurrence. Conclusion The management of the IVC after tumor resection depended on the tumor location and size. R0 resection provided a chance for long term survival.
What problem does this paper attempt to address?